| ATC kode | |
| L | Antineoplastiske og immunomodulerende midler |
| L01 | Antineoplastiske stoffer |
| L01A | Alkyleringsmidler |
| L01AA | Kvælstofsennepsgas-analoger |
| L01AA01 | Cyclophosphamid |
| L01AA02 | Chlorambucil |
| L01AA03 | Melphalan |
| L01AA05 | Chlormethin |
| L01AA06 | Ifosfamid |
| L01AA07 | Trofosfamid |
| L01AA08 | Prednimustin |
| L01AA09 | Bendamustin |
| L01AA10 | Melphalanflufenamid |
| L01AB | Alkylsulfonater |
| L01AB01 | Busulfan |
| L01AB02 | Treosulfan |
| L01AB03 | Mannosulfan |
| L01AC | Ethyleniminer |
| L01AC01 | Thiotepa |
| L01AC02 | Triaziquon |
| L01AC03 | Carboquon |
| L01AD | Nitrosoureastoffer |
| L01AD01 | Carmustin |
| L01AD02 | Lomustin |
| L01AD03 | Semustin |
| L01AD04 | Streptozocin |
| L01AD05 | Fotemustin |
| L01AD06 | Nimustin |
| L01AD07 | Ranimustin |
| L01AD08 | Uramustin |
| L01AG | Epoxider |
| L01AG01 | Etoglucid |
| L01AX | Andre alkyleringsmidler |
| L01AX01 | Mitobronitol |
| L01AX02 | Pipobroman |
| L01AX03 | Temozolomid |
| L01AX04 | Dacarbazin |
| L01B | Antimetabolitter |
| L01BA | Folsyre-analoger |
| L01BA01 | Methotrexat |
| L01BA03 | Raltitrexed |
| L01BA04 | Pemetrexed |
| L01BA05 | Pralatrexat |
| L01BB | Purin-analoger |
| L01BB02 | Mercaptopurin |
| L01BB03 | Tioguanin |
| L01BB04 | Cladribin |
| L01BB05 | Fludarabin |
| L01BB06 | Clofarabin |
| L01BB07 | Nelarabin |
| L01BC | Pyrimidin-analoger |
| L01BC01 | Cytarabin |
| L01BC02 | Fluoruracil |
| L01BC03 | Tegafur |
| L01BC04 | Carmofur |
| L01BC05 | Gemcitabin |
| L01BC06 | Capecitabin |
| L01BC07 | Azacitidin |
| L01BC08 | Decitabin |
| L01BC09 | Floxuridin |
| L01BC52 | Fluoruracil, kombinationer |
| L01BC53 | Tegafur, komb. |
| L01BC58 | Decitabin, kombinationer |
| L01BC59 | Trifluridin, kombinationer |
| L01C | Plantealkaloider og andre naturprodukter |
| L01CA | Vinca-alkaloider og analoger |
| L01CA01 | Vinblastin |
| L01CA02 | Vincristin |
| L01CA03 | Vindesin |
| L01CA04 | Vinorelbin |
| L01CA05 | Vinflunin |
| L01CA06 | Vintafolid |
| L01CB | Podophyllotoxin-derivater |
| L01CB01 | Etoposid |
| L01CB02 | Teniposid |
| L01CC | Colchicin-derivater |
| L01CC01 | Demecolcin |
| L01CD | Taxaner |
| L01CD01 | Paclitaxel |
| L01CD02 | Docetaxel |
| L01CD03 | Paclitaxel poliglumex |
| L01CD04 | Cabazitaxel |
| L01CD51 | Paclitaxel og encequidar |
| L01CE | Topoisomerase 1 hæmmere |
| L01CE01 | Topotecan |
| L01CE02 | Irinotecan |
| L01CE03 | Etirinotecan pegol |
| L01CE04 | Belotecan |
| L01CX | Andre plantealkaloider og naturprodukter |
| L01CX01 | Trabectedin |
| L01D | Cytotoksiske antibiotika og beslægtede stoffer |
| L01DA | Actinomyciner |
| L01DA01 | Dactinomycin |
| L01DB | Anthracycliner og beslægtede stoffer |
| L01DB01 | Doxorubicin |
| L01DB02 | Daunorubicin |
| L01DB03 | Epirubicin |
| L01DB04 | Aclarubicin |
| L01DB05 | Zorubicin |
| L01DB06 | Idarubicin |
| L01DB07 | Mitoxantron |
| L01DB08 | Pirarubicin |
| L01DB09 | Valrubicin |
| L01DB10 | Amrubicin |
| L01DB11 | Pixantron |
| L01DC | Andre cytotoxiske antibiotika |
| L01DC01 | Bleomycin |
| L01DC02 | Plicamycin |
| L01DC03 | Mitomycin |
| L01DC04 | Ixabepilon |
| L01DC05 | Utidelon |
| L01E | Proteinkinasehæmmere |
| L01EA | Bcr-abl tyrosinkinasehæmmere |
| L01EA01 | Imatinib |
| L01EA02 | Dasatinib |
| L01EA03 | Nilotinib |
| L01EA04 | Bosutinib |
| L01EA05 | Ponatinib |
| L01EA06 | Asciminib |
| L01EB | Epidermal vækstfaktor receptor (egfr)-tyrosinkinasehæmmere |
| L01EB01 | Gefitinib |
| L01EB02 | Erlotinib |
| L01EB03 | Afatinib |
| L01EB04 | Osimertinib |
| L01EB05 | Rociletinib |
| L01EB06 | Olmutinib |
| L01EB07 | Dacomitinib |
| L01EB08 | Icotinib |
| L01EB09 | Lazertinib |
| L01EB10 | Mobocertinib |
| L01EB11 | Aumolertinib |
| L01EC | B-raf serin-threoninkinase (braf) hæmmere |
| L01EC01 | Vemurafenib |
| L01EC02 | Dabrafenib |
| L01EC03 | Encorafenib |
| L01ED | Anaplastisk lymfom kinase (alk) hæmmere |
| L01ED01 | Crizotinib |
| L01ED02 | Ceritinib |
| L01ED03 | Alectinib |
| L01ED04 | Brigatinib |
| L01ED05 | Lorlatinib |
| L01EE | Mitogen-aktiverede proteinkinase (mek) hæmmere |
| L01EE01 | Trametinib |
| L01EE02 | Cobimetinib |
| L01EE03 | Binimetinib |
| L01EE04 | Selumetinib |
| L01EE05 | Mirdametinib |
| L01EF | Cyclin-afhængig kinase (cdk) hæmmere |
| L01EF01 | Palbociclib |
| L01EF02 | Ribociclib |
| L01EF03 | Abemaciclib |
| L01EG | Mammalian target of rapamycin (mtor) kinase hæmmere |
| L01EG01 | Temsirolimus |
| L01EG02 | Everolimus |
| L01EG03 | Ridaforolimus |
| L01EG04 | Sirolimus |
| L01EH | Human epidermal vækstfaktor receptor 2 (her2) tyrosinkinase hæmmere |
| L01EH01 | Lapatinib |
| L01EH02 | Neratinib |
| L01EH03 | Tucatinib |
| L01EJ | Janus associerede kinase (jak) hæmmere |
| L01EJ01 | Ruxolitinib |
| L01EJ02 | Fedratinib |
| L01EJ03 | Pacritinib |
| L01EJ04 | Momelotinib |
| L01EK | Vaskulær endotelial vækstfaktor receptor (vegfr)-tyrosinkinase hæmmere |
| L01EK01 | Axitinib |
| L01EK02 | Cediranib |
| L01EK03 | Tivozanib |
| L01EK04 | Fruquintinib |
| L01EL | Bruton's tyrosinkinase (btk) hæmmere |
| L01EL01 | Ibrutinib |
| L01EL02 | Acalabrutinib |
| L01EL03 | Zanubrutinib |
| L01EL04 | Orelabrutinib |
| L01EL05 | Pirtobrutinib |
| L01EL06 | Tirabrutinib |
| L01EM | Phosphatidylinositol-3-kinase (pi3k) hæmmere |
| L01EM01 | Idelalisib |
| L01EM02 | Copanlisib |
| L01EM03 | Alpelisib |
| L01EM04 | Duvelisib |
| L01EM05 | Parsaclisib |
| L01EN | Fibroblast vækstfaktor receptor (fgfr) tyrosinkinasehæmmere |
| L01EN01 | Erdafitinib |
| L01EN02 | Pemigatinib |
| L01EN03 | Infigratinib |
| L01EN04 | Futibatinib |
| L01EX | Andre proteinkinasehæmmere |
| L01EX01 | Sunitinib |
| L01EX02 | Sorafenib |
| L01EX03 | Pazopanib |
| L01EX04 | Vandetanib |
| L01EX05 | Regorafenib |
| L01EX06 | Masitinib |
| L01EX07 | Cabozantinib |
| L01EX08 | Lenvatinib |
| L01EX09 | Nintedanib |
| L01EX10 | Midostaurin |
| L01EX11 | Quizartinib |
| L01EX12 | Larotrectinib |
| L01EX13 | Gilteritinib |
| L01EX14 | Entrectinib |
| L01EX15 | Pexidartinib |
| L01EX17 | Capmatinib |
| L01EX18 | Avapritinib |
| L01EX19 | Ripretinib |
| L01EX21 | Tepotinib |
| L01EX22 | Selpercatinib |
| L01EX23 | Pralsetinib |
| L01EX24 | Surufatinib |
| L01EX25 | Umbralisib |
| L01EX26 | Sitravatinib |
| L01EX27 | Capivasertib |
| L01EX28 | Repotrectinib |
| L01F | Monoklonale antistoffer og antistof-lægemiddel-konjugater |
| L01FA | Anti-cd20 monoklonale antistoffer |
| L01FA01 | Rituximab |
| L01FA02 | Ofatumumab |
| L01FA03 | Obinutuzumab |
| L01FB | Anti-cd22 monoklonale antistoffer |
| L01FB01 | Inotuzumab ozogamicin |
| L01FB02 | Moxetumomab pasudotox |
| L01FC | Anti-cd38 monoklonale antistoffer |
| L01FC01 | Daratumumab |
| L01FC02 | Isatuximab |
| L01FD | Human epidermal vækstfaktor receptor 2 (her2) hæmmere |
| L01FD01 | Trastuzumab |
| L01FD02 | Pertuzumab |
| L01FD03 | Trastuzumab emtansin |
| L01FD04 | Trastuzumab deruxtecan |
| L01FD05 | Trastuzumab duocarmazin |
| L01FD06 | Margetuximab |
| L01FD07 | Zanidatamab |
| L01FE | Epidermal vækstfaktor receptor (egfr) hæmmere |
| L01FE01 | Cetuximab |
| L01FE02 | Panitumumab |
| L01FE03 | Necitumumab |
| L01FF | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) hæmmere |
| L01FF01 | Nivolumab |
| L01FF02 | Pembrolizumab |
| L01FF03 | Durvalumab |
| L01FF04 | Avelumab |
| L01FF05 | Atezolizumab |
| L01FF06 | Cemiplimab |
| L01FF07 | Dostarlimab |
| L01FF08 | Prolgolimab |
| L01FF09 | Tislelizumab |
| L01FF10 | Retifanlimab |
| L01FF11 | Sugemalimab |
| L01FF12 | Serplulimab |
| L01FF13 | Toripalimab |
| L01FG | Vaskulær endotelial vækstfaktor (vegf/vegfr) hæmmere |
| L01FG01 | Bevacizumab |
| L01FG02 | Ramucirumab |
| L01FX | Andre monoklonale antistoffer og antistof-lægemiddel-konjugater |
| L01FX01 | Edrecolomab |
| L01FX02 | Gemtuzumab ozogamicin |
| L01FX03 | Catumaxomab |
| L01FX04 | Ipilimumab |
| L01FX05 | Brentuximab vedotin |
| L01FX06 | Dinutuximab beta |
| L01FX07 | Blinatumomab |
| L01FX08 | Elotuzumab |
| L01FX09 | Mogamulizumab |
| L01FX10 | Olaratumab |
| L01FX11 | Bermekimab |
| L01FX12 | Tafasitamab |
| L01FX13 | Enfortumab vedotin |
| L01FX14 | Polatuzumab vedotin |
| L01FX15 | Belantamab mafodotin |
| L01FX16 | Oportuzumab monatox |
| L01FX17 | Sacituzumab govitecan |
| L01FX18 | Amivantamab |
| L01FX19 | Sabatolimab |
| L01FX20 | Tremelimumab |
| L01FX21 | Naxitamab |
| L01FX22 | Loncastuximab tesirin |
| L01FX23 | Tisotumab vedotin |
| L01FX24 | Teclistamab |
| L01FX25 | Mosunetuzumab |
| L01FX26 | Mirvetuximab soravtansin |
| L01FX27 | Epcoritamab |
| L01FX28 | Glofitamab |
| L01FX29 | Talquetamab |
| L01FX31 | Zolbetuximab |
| L01FX32 | Elranatamab |
| L01FX33 | Tarlatamab |
| L01FX34 | Odronextamab |
| L01FX35 | Datopotamab deruxtecan |
| L01FX36 | Patritumab deruxtecan |
| L01FY | Kombinationer af monoklonale antistoffer og antistof-lægemiddel-konjugat |
| L01FY01 | Pertuzumab og trastuzumab |
| L01FY02 | Nivolumab og relatlimab |
| L01FY03 | Prolgolimab og nurulimab |
| L01X | Andre antineoplastiske stoffer |
| L01XA | Platin-forbindelser |
| L01XA01 | Cisplatin |
| L01XA02 | Carboplatin |
| L01XA03 | Oxaliplatin |
| L01XA04 | Satraplatin |
| L01XA05 | Polyplatillen |
| L01XB | Methylhydraziner |
| L01XB01 | Procarbazin |
| L01XD | Sensibilatorer til fotodynamisk/stråle-terapi |
| L01XD01 | Porfimernatrium |
| L01XD03 | Methylaminolevulinat |
| L01XD04 | Aminolevulinsyre |
| L01XD05 | Temoporfin |
| L01XD06 | Efaproxiral |
| L01XD07 | Padeliporfin |
| L01XF | Retinoider til cancerbehandling |
| L01XF01 | Tretinoin |
| L01XF02 | Alitretinoin |
| L01XF03 | Bexaroten |
| L01XG | Proteasomhæmmere |
| L01XG01 | Bortezomib |
| L01XG02 | Carfilzomib |
| L01XG03 | Ixazomib |
| L01XH | Histondeacetylase (hdac) hæmmere |
| L01XH01 | Vorinostat |
| L01XH02 | Romidepsin |
| L01XH03 | Panobinostat |
| L01XH04 | Belinostat |
| L01XH05 | Entinostat |
| L01XH06 | Tucidinostat |
| L01XH07 | Resminostat |
| L01XJ | Hedgehog pathway hæmmere |
| L01XJ01 | Vismodegib |
| L01XJ02 | Sonidegib |
| L01XJ03 | Glasdegib |
| L01XK | Poly (adp-ribose) polymerase (parp) hæmmere |
| L01XK01 | Olaparib |
| L01XK02 | Niraparib |
| L01XK03 | Rucaparib |
| L01XK04 | Talazoparib |
| L01XK05 | Veliparib |
| L01XK06 | Pamiparib |
| L01XK52 | Niraparib og abirateron |
| L01XL | Antineoplastisk celle- og genterapi |
| L01XL01 | Sitimagen ceradenovec |
| L01XL02 | Talimogen laherparepvec |
| L01XL03 | Axicabtagen ciloleucel |
| L01XL04 | Tisagenlecleucel |
| L01XL05 | Ciltacabtagen autoleucel |
| L01XL06 | Brexucabtagen autoleucel |
| L01XL07 | Idecabtagen vicleucel |
| L01XL08 | Lisocabtagene maraleucel |
| L01XL09 | Tabelecleucel |
| L01XL10 | Nadofaragen firadenovec |
| L01XL11 | Lifileucel |
| L01XL12 | Obecabtagen autoleucel |
| L01XM | Isocitrat dehydrogenase (idh) hæmmere |
| L01XM01 | Enasidenib |
| L01XM02 | Ivosidenib |
| L01XM03 | Olutasidenib |
| L01XM04 | Vorasidenib |
| L01XU | Andre antineoplastiske stoffer (fortsat) |
| L01XX | Andre neoplastiske stoffer |
| L01XX01 | Amsacrin |
| L01XX02 | Asparaginase |
| L01XX03 | Altretamin |
| L01XX05 | Hydroxycarbamid |
| L01XX07 | Lonidamin |
| L01XX08 | Pentostatin |
| L01XX10 | Masoprocol |
| L01XX11 | Estramustin |
| L01XX16 | Mitoguazon |
| L01XX18 | Tiazofurin |
| L01XX23 | Mitotan |
| L01XX24 | Pegaspargase |
| L01XX27 | Arsentrioxid |
| L01XX29 | Denileukin diftitox |
| L01XX33 | Celecoxib |
| L01XX35 | Anagrelid |
| L01XX36 | Oblimersen |
| L01XX40 | Omacetaxine mepesuccinat |
| L01XX41 | Eribulin |
| L01XX44 | Aflibercept |
| L01XX52 | Venetoclax |
| L01XX53 | Vosaroxin |
| L01XX57 | Plitidepsin |
| L01XX58 | Epacadostat |
| L01XX66 | Selinexor |
| L01XX67 | Tagraxofusp |
| L01XX69 | Lurbinectedin |
| L01XX72 | Tazemetostat |
| L01XX73 | Sotorasib |
| L01XX74 | Belzutifan |
| L01XX75 | Tebentafusp |
| L01XX77 | Adagrasib |
| L01XX78 | Navitoclax |
| L01XX79 | Eflornithin |
| L01XX80 | Imetelstat |
| L01XX81 | Nirogacestat |
| L01XX82 | Darinaparsin |
| L01XX83 | Paratoluenesulfonamid |
| L01XX84 | Pelabresib |
| L01XX85 | Idroxioliesyre |
| L01XX86 | Calaspargase pegol |
| L01XY | Kombinationer af antineoplastiske stoffer |
| L01XY01 | Cytarabin og daunorubicin |
| L01XY04 | Bifikafusp alfa og onfekafusp alfa |
| L02 | Endocrin terapi |
| L02A | Hormoner og beslægtede stoffer |
| L02AA | Østrogener |
| L02AA01 | Diethylstilbestrol |
| L02AA02 | Polyestradiolphosphat |
| L02AA03 | Ethinylestradiol |
| L02AA04 | Fosfestrol |
| L02AB | Gestagener |
| L02AB01 | Megestrol |
| L02AB02 | Medroxyprogesteron |
| L02AB03 | Gestonoron |
| L02AE | Gonadotropin-releasing hormon analoger |
| L02AE01 | Buserelin |
| L02AE02 | Leuprorelin |
| L02AE03 | Goserelin |
| L02AE04 | Triptorelin |
| L02AE05 | Histrelin |
| L02AE51 | Leuprorelin og bicalutamid |
| L02AX | Andre hormoner |
| L02B | Hormon-antagonister og lign. stoffer |
| L02BA | Anti-østrogener |
| L02BA01 | Tamoxifen |
| L02BA02 | Toremifen |
| L02BA03 | Fulvestrant |
| L02BA04 | Elacestrant |
| L02BB | Anti-androgener |
| L02BB01 | Flutamid |
| L02BB02 | Nilutamid |
| L02BB03 | Bicalutamid |
| L02BB04 | Enzalutamid |
| L02BB05 | Apalutamid |
| L02BB06 | Darolutamid |
| L02BG | Aromatase inhibitorer |
| L02BG01 | Aminogluthetimid |
| L02BG02 | Formestan |
| L02BG03 | Anastrozol |
| L02BG04 | Letrozol |
| L02BG05 | Vorozol |
| L02BG06 | Exemestan |
| L02BX | Andre hormon-antagonister og lign. stoffer |
| L02BX01 | Abarelix |
| L02BX02 | Degarelix |
| L02BX03 | Abirateron |
| L02BX04 | Relugolix |
| L02BX53 | Abirateron og kortikosteroider |
| L03 | Immunstimulerende midler |
| L03A | Immunstimulanter |
| L03AA | Kolonistimulerende faktorer |
| L03AA02 | Filgrastim |
| L03AA03 | Molgramostim |
| L03AA09 | Sargramostim |
| L03AA10 | Lenograstim |
| L03AA12 | Ancestim |
| L03AA13 | Pegfilgrastim |
| L03AA14 | Lipegfilgrastim |
| L03AA15 | Balugrastim |
| L03AA16 | Empegfilgrastim |
| L03AA17 | Pegteograstim |
| L03AA18 | Efbemalenograstim alfa |
| L03AA19 | Eflapegrastim |
| L03AB | Interferoner |
| L03AB01 | Interferon alfa naturligt |
| L03AB02 | Interferon beta naturligt |
| L03AB03 | Interferon gamma |
| L03AB04 | Interferon alfa-2a |
| L03AB05 | Interferon alfa-2b |
| L03AB06 | Interferon alfa-n1 |
| L03AB07 | Interferon beta-1a |
| L03AB08 | Interferon beta-1b |
| L03AB09 | Interferon alfacon-1 |
| L03AB10 | Peginterferon alfa-2b |
| L03AB11 | Peginterferon alfa-2a |
| L03AB12 | Albinterferon alfa-2b |
| L03AB13 | Peginterferon beta-1a |
| L03AB14 | Cepeginterferon alfa-2b |
| L03AB15 | Ropeginterferon alfa-2b |
| L03AB16 | Peginterferon alfacon-2 |
| L03AB17 | Sampeginterferon beta-1a |
| L03AB60 | Peginterferon-alfa-2b, komb. |
| L03AB61 | Peginterferon alfa-2a, kombinationer |
| L03AC | Interleukiner |
| L03AC01 | Aldesleukin |
| L03AC02 | Oprelvekin |
| L03AX | Andre immunstimulanter |
| L03AX01 | Lentinan |
| L03AX02 | Roquinimex |
| L03AX03 | Bcg vaccine |
| L03AX04 | Pegademase |
| L03AX05 | Pidotimod |
| L03AX07 | Poly i:c |
| L03AX08 | Poly iclc |
| L03AX09 | Thymopentin |
| L03AX10 | Immunocyanin |
| L03AX11 | Tasonermin |
| L03AX12 | Melanoma vaccine |
| L03AX13 | Glatirameracetat |
| L03AX14 | Histamindihydrochlorid |
| L03AX15 | Mifamurtid |
| L03AX16 | Plerixafor |
| L03AX17 | Sipuleucel-t |
| L03AX18 | Cridanimod |
| L03AX19 | Dasiprotimut-t |
| L03AX21 | Elapegademase |
| L03AX22 | Leniolisib |
| L03AX23 | Motixafortid |
| L03AX24 | Mavorixafor |
| L04 | Immunsuppressiva |
| L04A | Immunsuppressiva |
| L04AA | Selektive immunsuppressiva |
| L04AA03 | Antilymfocyt immunoglobulin |
| L04AA04 | Antithymocyt immunoglobulin |
| L04AA06 | Mycophenolsyre |
| L04AA15 | Alefacept |
| L04AA19 | Gusperimus |
| L04AA22 | Abetimus |
| L04AA24 | Abatacept |
| L04AA28 | Belatacept |
| L04AA32 | Apremilast |
| L04AA40 | Cladribin |
| L04AA41 | Imlifidase |
| L04AA48 | Belumosudil |
| L04AA58 | Efgartigimod alfa |
| L04AA60 | Remibrutinib |
| L04AB | Tumor necrosis factor alpha (tnf-alfa) hæmmere |
| L04AB01 | Etanercept |
| L04AB02 | Infliximab |
| L04AB03 | Afelimomab |
| L04AB04 | Adalimumab |
| L04AB05 | Certolizumab pegol |
| L04AB06 | Golimumab |
| L04AB07 | Opinercept |
| L04AC | Interleukinhæmmere |
| L04AC01 | Daclizumab |
| L04AC02 | Basiliximab |
| L04AC03 | Anakinra |
| L04AC04 | Rilonacept |
| L04AC05 | Ustekinumab |
| L04AC07 | Tocilizumab |
| L04AC08 | Canakinumab |
| L04AC09 | Briakinumab |
| L04AC10 | Secukinumab |
| L04AC11 | Siltuximab |
| L04AC12 | Brodalumab |
| L04AC13 | Ixekizumab |
| L04AC14 | Sarilumab |
| L04AC15 | Sirukumab |
| L04AC16 | Guselkumab |
| L04AC17 | Tildrakizumab |
| L04AC18 | Risankizumab |
| L04AC19 | Satralizumab |
| L04AC20 | Netakimab |
| L04AC21 | Bimekizumab |
| L04AC22 | Spesolimab |
| L04AC23 | Olokizumab |
| L04AC24 | Mirikizumab |
| L04AC25 | Levilimab |
| L04AC26 | Goflikicept |
| L04AD | Calcineurinhæmmere |
| L04AD01 | Ciclosporin |
| L04AD02 | Tacrolimus |
| L04AD03 | Voclosporin |
| L04AE | Sphingosin 1-phosphat (s1p) receptormodulatorer |
| L04AE01 | Fingolimod |
| L04AE02 | Ozanimod |
| L04AE03 | Siponimod |
| L04AE04 | Ponesimod |
| L04AE05 | Etrasimod |
| L04AF | Janus associerede kinase (jak) hæmmere |
| L04AF01 | Tofacitinib |
| L04AF02 | Baricitinib |
| L04AF03 | Upadacitinib |
| L04AF04 | Filgotinib |
| L04AF05 | Itacitinib |
| L04AF06 | Peficitinib |
| L04AF07 | Deucravacitinib |
| L04AF08 | Ritlecitinib |
| L04AG | Monoklonale antistoffer |
| L04AG01 | Muromonab-cd3 |
| L04AG02 | Efalizumab |
| L04AG03 | Natalizumab |
| L04AG04 | Belimumab |
| L04AG05 | Vedolizumab |
| L04AG06 | Alemtuzumab |
| L04AG07 | Begelomab |
| L04AG08 | Ocrelizumab |
| L04AG09 | Emapalumab |
| L04AG10 | Inebilizumab |
| L04AG11 | Anifrolumab |
| L04AG12 | Ofatumumab |
| L04AG13 | Teprotumumab |
| L04AG14 | Ublituximab |
| L04AG15 | Divozilimab |
| L04AG16 | Rozanolixizumab |
| L04AG17 | Seniprutug |
| L04AH | Mammalian target of rapamycin (mtor) kinasehæmmere |
| L04AH01 | Sirolimus |
| L04AH02 | Everolimus |
| L04AJ | Komplementhæmmere |
| L04AJ01 | Eculizumab |
| L04AJ02 | Ravulizumab |
| L04AJ03 | Pegcetacoplan |
| L04AJ04 | Sutimlimab |
| L04AJ05 | Avacopan |
| L04AJ06 | Zilucoplan |
| L04AJ07 | Crovalimab |
| L04AJ08 | Iptacopan |
| L04AJ09 | Danicopan |
| L04AJ10 | Vilobelimab |
| L04AJ11 | Pozelimab |
| L04AK | Dihydroorotat dehydrogenase (dhodh) hæmmere |
| L04AK01 | Leflunomid |
| L04AK02 | Teriflunomid |
| L04AX | Andre immunosuppressiva |
| L04AX01 | Azathioprin |
| L04AX02 | Thalidomid |
| L04AX03 | Methotrexat |
| L04AX04 | Lenalidomid |
| L04AX05 | Pirfenidon |
| L04AX06 | Pomalidomid |
| L04AX07 | Dimethylfumarat |
| L04AX08 | Darvadstrocel |
| L04AX09 | Diroximelfumarat |
| L04AX10 | Tegomilfumarat |
